These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24247174)
1. Associations of obesity, physical activity and diet with benign prostatic hyperplasia and lower urinary tract symptoms. Raheem OA; Parsons JK Curr Opin Urol; 2014 Jan; 24(1):10-4. PubMed ID: 24247174 [TBL] [Abstract][Full Text] [Related]
2. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association]. Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A; Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093 [TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ; Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338 [TBL] [Abstract][Full Text] [Related]
5. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? Silva J; Silva CM; Cruz F Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531 [TBL] [Abstract][Full Text] [Related]
6. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519 [TBL] [Abstract][Full Text] [Related]
7. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934 [TBL] [Abstract][Full Text] [Related]
8. Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? Fusco F; Arcaniolo D; Creta M; Piccinocchi G; Arpino G; Laringe M; Piccinocchi R; Longo N; Verze P; Mangiapia F; Imperatore V; Mirone V World J Urol; 2015 May; 33(5):685-9. PubMed ID: 25491675 [TBL] [Abstract][Full Text] [Related]
9. Review of exercise and the risk of benign prostatic hyperplasia. Sea J; Poon KS; McVary KT Phys Sportsmed; 2009 Dec; 37(4):75-83. PubMed ID: 20048544 [TBL] [Abstract][Full Text] [Related]
10. Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia. Singapore Urological Association Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Guidelines Committee 2015 Singapore Med J; 2017 Aug; 58(8):473-480. PubMed ID: 28848988 [TBL] [Abstract][Full Text] [Related]
11. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events. Mirone V; Sessa A; Giuliano F; Berges R; Kirby M; Moncada I Int J Clin Pract; 2011 Sep; 65(9):1005-13. PubMed ID: 21718399 [TBL] [Abstract][Full Text] [Related]
12. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. Parsons JK J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143 [TBL] [Abstract][Full Text] [Related]
13. Lifestyle and lower urinary tract symptoms: what is the correlation in men? Lin PH; Freedland SJ Curr Opin Urol; 2015 Jan; 25(1):1-5. PubMed ID: 25393271 [TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment. Mobley D; Feibus A; Baum N Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641 [TBL] [Abstract][Full Text] [Related]
16. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Vignozzi L; Gacci M; Maggi M Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190 [TBL] [Abstract][Full Text] [Related]
17. BPH: big disease with a little name. Reich O Curr Opin Urol; 2014 Jan; 24(1):1-2. PubMed ID: 24247175 [No Abstract] [Full Text] [Related]
18. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Rosen RC Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195 [TBL] [Abstract][Full Text] [Related]
19. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Miner M; Rosenberg MT; Perelman MA Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576 [TBL] [Abstract][Full Text] [Related]
20. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies. Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]